Releases
Patients facing the clinical dead-end of acquired resistance to FGFR inhibitor therapy now have an alternative. On August 6, 2026, China’s National Medical Products Administration approved TransThera Sciences' Yochanra, the first drug globally designed to specifically target and overcome resistance mutations in patients with advanced cholangiocarcinoma.
Releases
Actress Isabelle Huppert has stepped behind the camera for FAMILIARITÉ, a short film exploring the intersection of literature and memory. Shot entirely on the compact DJI Osmo Pocket 4P, the project bridges the legacies of 19th-century French novelist George Sand and Song-dynasty poet Li Qingzhao through a series of intimate, wordless vignettes.
Releases
Kyoto-based ROHM Co., Ltd. has unveiled its second-generation terahertz wave oscillation device, achieving a fourfold increase in output power over its predecessor. By leveraging resonant tunneling diodes, the company aims to lower the barrier for research institutions and developers looking to integrate high-frequency sensing into compact, non-destructive testing systems.
Releases
Coway Co., Ltd. recorded a significant financial upturn in the second quarter of 2026, posting KRW 1,442.2 billion in revenue, a 14.6% increase compared to the previous year. This performance, bolstered by strong domestic rental growth and robust international sales, highlights the company's expanding influence in the premium home wellness market.
Releases
Olympus Corporation posted 240.4 billion Japanese yen in revenue for the first quarter of fiscal year 2027, marking a 16% year-on-year increase. While the company faced temporary supply disruptions in its surgical division, robust demand within its gastrointestinal business sustained overall momentum and kept full-year guidance intact.
Releases
Isabelle Huppert has moved behind the camera for FAMILIARITÉ, a short film exploring the resonance of 19th-century French writer George Sand and Song-dynasty poet Li Qingzhao. Shot entirely on the pocket-sized DJI Osmo Pocket 4P, the project seeks to bridge centuries of female expression through a handheld, intimate lens.
Releases
With forest coverage climbing from 11% to 35.1% in less than a decade, Xiong’an represents a deliberate attempt to redefine urban development in northern China. By prioritizing environmental restoration alongside a dense network of digital sensors, the city aims to balance rapid construction with long-term ecological resilience and resident-focused services.
Releases
The New York-based Rosen Law Firm is probing potential breaches of fiduciary duty by the board and executive officers at BellRing Brands, Inc. The investigation targets the conduct of company leadership, prompting a call for shareholders to come forward as the firm evaluates a possible legal challenge.
Releases
Investors who purchased Hertz Global Holdings common stock between May 7 and June 23, 2026, have until September 22 to move the court for lead plaintiff status. The Rosen Law Firm is spearheading the litigation, alleging the company misled shareholders regarding its liquidity and the impact of the used-car market.
Releases
Ventilation manufacturer Systemair has published its 2025/26 sustainability statement, detailing a 10 percent reduction in Scope 1 and 2 emissions and a significant drop in workplace injuries. The report marks the company's first submission under the Corporate Sustainability Reporting Directive, reflecting a shift toward stricter environmental and social governance.
Releases
San Francisco-based Animotion Robotics has unveiled Éloi, a bionic entity designed for human coexistence rather than utilitarian labor. Departing from the industry standard of task-oriented automation, the robot features a proprietary cognitive core that grants it the agency to pause, remain silent, or express fatigue based on its own internal state.
Releases
When a 7.8-magnitude earthquake devastated northern Pakistan in 2005, it claimed 73,000 lives and left a generation of engineers determined to prevent future catastrophes. Today, that trauma drives the China-Pakistan Belt and Road Joint Laboratory, where researchers use AI and big data to fortify infrastructure against natural disasters.
Releases
Shares of AstraZeneca slid 5.7% last month after the pharmaceutical giant revealed its experimental heart treatment, Wainua, missed key clinical targets. Now, the New York-based Pomerantz Law Firm is probing whether the company’s leadership misled stakeholders regarding the viability of the late-stage Phase-3 CARDIO-TTransform trial.
Releases
A sharp 23.9% drop in Zevra Therapeutics stock has triggered a formal investigation by Pomerantz LLP. The inquiry centers on potential securities fraud following the European Medicines Agency's rejection of the company's application for its lead drug candidate, arimoclomol, intended to treat Niemann-Pick disease type C.
Releases
A 17.6% drop in Celcuity Inc. shares following the company's delayed commercial launch announcement has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether the breast cancer therapy developer and its leadership engaged in securities fraud or unlawful business practices during the lead-up to the regulatory approval.
Releases
A 6.74 percent drop in Agios Pharmaceuticals’ share price has triggered a formal investigation by Pomerantz LLP. The firm is examining potential securities fraud and unlawful business practices after the company abandoned the development of its oral pyruvate kinase activator, tebapivat, citing lackluster results from a recent Phase 2 trial.
Releases
Pathward Financial faces a formal investigation by Pomerantz LLP following a fiscal third-quarter report that revealed a sharp spike in nonperforming loans. The probe centers on potential securities fraud or unlawful business practices after the company missed earnings expectations and slashed its full-year guidance, triggering a significant drop in share value.
Releases
A 9% slide in Noble Corporation shares has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows the company’s July 27 disclosure of a $43 million financial hit stemming from rig suspensions in Brazil and a subsequent downgrade of its full-year EBITDA guidance.
Releases
A 25.21% plummet in IBM stock on July 14, 2026, has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The firm is examining whether company leadership misled shareholders after a series of failed large deals and a significant shortfall in transaction processing performance crippled quarterly results.
Releases
Allegations of systematically misclassified expenses have triggered a probe into Alignment Healthcare, targeting potential securities fraud after a whistleblower complaint surfaced in July. The investigation centers on claims that the company inflated financial performance metrics, including Adjusted EBITDA, to distort its reported results and executive compensation.
Releases
A 7.84% drop in share price followed Americold Realty Trust’s July 23 announcement that it would terminate major distribution agreements in Pennsylvania and Connecticut. The sudden disclosure of an expected $305 million to $320 million non-cash impairment charge has prompted Pomerantz LLP to launch an investigation into potential securities fraud.
Releases
A sharp drop in share price following a disclosure of significant credit losses has triggered an investigation by Pomerantz LLP into FirstSun Capital Bancorp. The firm is examining whether company leadership engaged in unlawful business practices or securities fraud, potentially affecting shareholder value after a July 9 announcement.
Releases
A 12.65% drop in AppLovin Corporation’s share price has triggered a formal investigation by Pomerantz LLP. The firm is scrutinizing whether company leadership engaged in securities fraud or unlawful business practices, specifically centering on the performance of the tech firm’s recently launched AI-driven merchant platform.
Releases
A 21 percent drop in Karyopharm Therapeutics stock following the disclosure of executive retention bonuses has triggered a formal investigation by Pomerantz LLP. The law firm is currently scrutinizing whether the company’s leadership engaged in securities fraud or unlawful business practices regarding these multimillion-dollar compensation packages.
Releases
A 12.38% single-day stock drop followed by a 22.51% slide has triggered a formal investigation into Wheels Up Experience Inc. New York-based law firm Pomerantz LLP is now probing whether the company’s leadership misled investors or engaged in unlawful business practices regarding its financial reporting and recent corporate restructuring.
Releases
Ionis Pharmaceuticals shares plummeted 23.9% on July 9, 2026, after the company revealed its late-stage CARDIO-TTransform trial for the amyloid cardiomyopathy treatment Wainua failed to hit its primary endpoint. The stock dropped $20.19 to close at $64.27, triggering a formal inquiry by the law firm Pomerantz LLP.
Releases
A 12 percent stock drop following a January downgrade has triggered a formal investigation into AST SpaceMobile. New York-based Pomerantz LLP is now examining whether the company or its executives engaged in securities fraud, seeking to represent investors who suffered losses amid mounting competition and financial volatility.
Releases
A 21.63% single-day collapse in stock value has triggered a formal investigation into Albertsons Companies, Inc. New York-based Pomerantz LLP is probing potential securities fraud and unlawful business practices following the retailer's failure to meet consensus earnings expectations and a subsequent downward revision of its full-year financial outlook.
Releases
A 21% single-day stock plunge following weak second-quarter results has triggered a formal investigation into Lennox International. New York-based Pomerantz LLP is now scrutinizing the climate surrounding the company’s financial disclosures, probing whether officers or directors misled shareholders regarding the firm's true performance and market outlook.
Releases
Coastal Financial Corporation shares plummeted over 43% following a $42.1 million quarterly loss, prompting New York-based Pomerantz LLP to open an investigation into potential securities fraud. The inquiry centers on whether leadership misled shareholders regarding the financial stability of the company's CCBX consumer loan portfolio.
